Clinical Trial Update: PF-00299804 Monotherapy in Patients With HER-2 Positive Advance Gastric Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial of PF-00299804 (neratinib) as monotherapy in HER2-positive advanced gastric cancer has completed enrollment and the study status indicates it is f…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Drugs mentioned

• PF-00299804 (neratinib) (neratinib)

Snippet

Sponsor: Seoul National University Hospital | Conditions: Advanced Gastric Cancer, HER2 | Phase 2 | Status: COMPLETED